drugset / Trial / NCT04017052

Application of a TBE-Vaccine in Obese Persons

NCT04017052 ↗

Phase 4 Unknown 73 enrolled Medical University of Vienna
NaSingle-groupOpen-labelPrevention

Summary

Obese people have an altered immune responsiveness. The present study investigates whether this influences immune responses to booster vaccinations (i. e. booster vaccination with TBE vaccine "FSME Immun") and if a modification of vaccination schedules is needed. Obese adults (BMI \>30) \>18 - 60 years are compared with adults with normal weight (BMI \<25) concerning TBE-NT- antibody titers, TBE- NT antibody titer course and cellular immunity. Metabolic parameters and sexual hormones will be tested and compared as well.

Timeline

Start
2015-04-15
Primary completion
2020-02-07
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject FSME-IMMUN Vaccine Vaccine — Intramuscular